中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

54 records (took 0.02 seconds)

    법제된 비상을 함유하는 면역력 증강을 위한 약학적 조성물
    1.
    发明申请
    법제된 비상을 함유하는 면역력 증강을 위한 약학적 조성물 审中-公开
    增强免疫力的药物组合物，包含法律紧急情况

    公开(公告)号：WO2017069458A1

    公开(公告)日：2017-04-27

    申请号：PCT/KR2016/011514

    申请日：2016-10-14

    Applicant: 손영태 ,  이상봉

    Inventor： 손영태 ,  이상봉

    IPC: A61K33/36 ,  A61K31/285 ,  A61K9/14 ,  A61K36/725 ,  A61K36/9068 ,  A61K35/644

    CPC classification number: A61K9/14 ,  A61K31/285 ,  A61K33/36 ,  A61K35/644 ,  A61K36/725 ,  A61K36/9068

    Abstract: 본 발명은 면역이 저하된 만성 감기, 만성 피로증후군 환자뿐만 아니라 암환자의 면역기능을 증가시키기 위한 법제된 비상을 함유하는 약학적 조성물, 더더욱 이 법제된 비상을 정제수, 프로폴리스액, 발효 프로폴리스액, 인삼 추출액, 발효 인삼 추출액, 산양삼 추출액, 산양산삼 추출액, 발효 산양삼 추출액, 발효 산양산삼 추출액, 수소수 및 알칼리환원수로 이루어진 군에서 선택되는 어느 하나 이상에 용해시켜 제조되는 면역 증강을 위한 약학적 조성물에 관한 것이다. 본 발명에 따른 약학적 조성물을 항암치료 시 면역증강제로서의 효과가 뛰어나며, 또한 만성감기환자와 같은 상대적으로 면역력이 낮은 정상인에게도 안정성이 확보된 고효율의 면역증강제로서 우수한 효과를 보인다.

    Abstract translation:

    本发明是药物组合物，进一步的纯化水至紧急法制慢性伤口的免疫力下降，慢性疲劳综合症，以及含有一个法律紧急用于增加癌症患者的免疫功能 ，蜂胶溶液，发酵蜂胶溶液，通过溶解人参提取物，发酵人参提取物，sanyangsam提取物，山羊野山参提取物，发酵sanyangsam提取物，发酵的山羊野山参提取物，可以从由少数和碱性水组成的组中的至少任何一个 用于免疫增强的药物组合物。 作为化疗期间佐剂优异的效果，根据本发明的药物组合物，并显示出因为即使相对低的正常的免疫系统，如慢性伤口的患者稳定性确保高效率的佐剂的优良效果。

    EXTENDED CYCLE MULTIPHASIC ORAL CONTRACEPTIVE METHOD
    3.
    发明申请
    EXTENDED CYCLE MULTIPHASIC ORAL CONTRACEPTIVE METHOD 审中-公开
    扩展循环多功能口服合同方法

    公开(公告)号：WO2007106264A2

    公开(公告)日：2007-09-20

    申请号：PCT/US2007003508

    申请日：2007-02-09

    Applicant: WARNER CHILCOTT CO INC ,  ELLMAN HERMAN

    Inventor： ELLMAN HERMAN

    IPC: A61K31/285 ,  A61K31/565 ,  A61K31/567 ,  A61K31/57 ,  A61K45/06 ,  A61P15/00

    CPC classification number: A61K45/06 ,  A61K31/285 ,  A61K31/56 ,  A61K31/565 ,  A61K31/567 ,  A61K31/57 ,  A61K2300/00

    Abstract: A multiphasic method of contraception comprising the steps of sequentially administering to a female of child bearing age a Phase I composition containing a progestogen in an amount equivalent to about 0.3 to about 1.5 mg norethiiidrpne acetate and an estrogen in an amount equivalent to about 5 to aboµt 15 mcg of ethinyl estradiol for about 7 to about 14 days; a Phase II composition containing a progestogen in an amount equivalent to about 0.3 to about 1.5 mg of norethindrone acetate and an estrogen in an amount equivalent to about 10 to about 25 meg of ethinyl estradiol for about 14 to about 22 days; a Phase m composition containing a progestogen in an amount equivalent to about 0.3 to about 1.5 mg of norethindrone acetate and an estrogen in an amount equivalent to about 15 to about 35 meg of ethinyl estradiol for about 20 to about 31 days; and an optional Phase IV composition containing (i) an estrogen in an amount equivalent to about 5 to about 20 meg of ethinyl estradiol, or (ii) a placebo or a non-steroidal component, or (iii) a combination of (i) and (ii), for about 2 to about 8 days. The ethinyl estradiol equivalent amount of estrogen in each of the successive Phases II and III is at least 5 meg greater than the ethinyl estradiol equivalent amount of estrogen in the immediately-preceding phase.

    Abstract translation: 一种多相避孕方法，包括以下步骤：向育龄女性依次施用含有相当于约0.3至约1.5mg炔诺酮乙酸盐的孕激素的相I组合物和相当于约5至 15毫克乙炔雌二醇约7至约14天; 含有相当于约0.3至约1.5mg的醋酸炔诺酮的孕激素和相当于约10至约25mcg乙炔雌二醇的雌激素约14至约22天的II期组合物; 该组合物含有相当于约0.3至约1.5mg醋酸炔诺酮的量的孕激素和相当于约15至约35mcg炔雌醇的雌激素约20至约31天; 和任选的IV期组合物，其包含（i）相当于约5至约20mcg乙炔雌二醇的雌激素，或（ii）安慰剂或非甾体组分，或（iii）（i） 和（ii）约2至约8天。 在连续的第二阶段和第三阶段中，雌激素的乙炔雌二醇当量相当于前一相中雌激素的乙炔雌二醇量的至少5兆比特。

    INHIBITION OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE HYDROLASE AMINO TERMINUS AND USES THEREOF
    9.
    发明申请
    INHIBITION OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE HYDROLASE AMINO TERMINUS AND USES THEREOF 审中-公开
    可溶性环氧化物水解酶氨基末端磷酸酶活性的抑制及其用途

    公开(公告)号：WO2007022059A3

    公开(公告)日：2007-10-11

    申请号：PCT/US2006031589

    申请日：2006-08-14

    Applicant: UNIV CALIFORNIA ,  HAMMOCK BRUCE D ,  MORISSEAU CHRISTOPHE ,  NEWMAN JOHN W

    Inventor： HAMMOCK BRUCE D ,  MORISSEAU CHRISTOPHE ,  NEWMAN JOHN W

    IPC: C12N9/00 ,  C12N9/14

    CPC classification number: A61K31/285 ,  C07C305/06 ,  C07C305/10

    Abstract: Inhibitors of the phosphatase activity of soluble epoxide hydrolase (sEH) are provided and are useful for in the treatment of diseases. These Inhibitors are based on derivatives of various epoxide hydrolase substrates that mimic the enzyme substrate so that there Is stable Interaction with the enzyme catalytic site. These inhibitors are potentially useful for the treatment of hypertension, vascular inflammation, renal inflammation, and lung disease.

    Abstract translation: 提供可溶性环氧化物水解酶（sEH）的磷酸酶活性的抑制剂，可用于治疗疾病。 这些抑制剂基于模拟酶底物的各种环氧化物水解酶底物的衍生物，使得与酶催化位点具有稳定的相互作用。 这些抑制剂可用于治疗高血压，血管炎症，肾脏炎症和肺部疾病。

Patent Agency Ranking